MedPath

POTASSIUM ACETATE INJECTION

POTASSIUM ACETATE INJECTION

Dormant
DIN Number

02139553

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02139553
AIG Number0107304002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA17 POTASSIUM ACETATE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

POTASSIUM ACETATEActive
Strength: 392 MG / ML
Monograph: POTASSIUM ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.